Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JCOG1217 Steroid EESD P3
jRCTs031180118Phase 3Completed
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Oct 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in Esophageal Squamous Cell Carcinoma (ESCC), esophageal cancer and Esophageal stricture comparing Local triamcinolone injection with Oral prednisolone (2 arms). Primary endpoint: Stricture-free survival. Started Oct 2014; status: completed.
02
Drugs
triamcinolone acetonideprednisolone
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)esophageal cancerEsophageal stricture
Beyond the preview
Go deeper on jRCTs031180118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180118.